Projects per year
Fingerprint Dive into the research topics where Jaime R Merchan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Neoplasms
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Measles virus
Medicine & Life Sciences
Renal Cell Carcinoma
Medicine & Life Sciences
Deoxyglucose
Medicine & Life Sciences
Pancreatic Neoplasms
Medicine & Life Sciences
Oncolytic Viruses
Medicine & Life Sciences
15-hydroxyprostaglandin dehydrogenase
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2006 2017
- 2 Finished
Oncolytic Viruses
Neoplasms
Viruses
Measles virus
Oncogenic Viruses
Biomarkers for VEGF and mTOR Blockade in Advanced Renal Cancer
9/19/06 → 8/31/09
Project: Research project
Kidney Neoplasms
Vascular Endothelial Growth Factor A
Renal Cell Carcinoma
Biomarkers
Therapeutics
Research Output 1998 2019
7
Citations
(Scopus)
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
Wilky, B. A., Trucco, M. M., Subhawong, T., Florou, V., Park, W., Kwon, D., Wieder, E., Kolonias, D., Rosenberg, A., Kerr, D., Sfakianaki, E., Foley, M., Merchan, J. R., Komanduri, K. V. & Trent, J. C., Jun 1 2019, In : The Lancet Oncology. 20, 6, p. 837-848 12 p.Research output: Contribution to journal › Article
Alveolar Soft Part Sarcoma
Sarcoma
Disease-Free Survival
Therapeutics
pembrolizumab
5
Citations
(Scopus)
Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours
Mir, O., Azaro, A., Merchan, J. R., Chugh, R., Trent, J., Rodon, J., Ohnmacht, U., Diener, J. T., Smith, C., Yuen, E., Oakley, G. J., Le Cesne, A., Soria, J. C., Benhadji, K. A. & Massard, C., Nov 1 2018, In : European Journal of Cancer. 103, p. 88-97 10 p.Research output: Contribution to journal › Article
Gastrointestinal Stromal Tumors
Sarcoma
Leiomyosarcoma
Safety
Disease-Free Survival
3
Citations
(Scopus)
The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma
Palacio, S., Hosein, P., Reis, I., Akunyili, I. I., Ernani, V., Pollack, T., Macintyre, J., Restrepo, M. H., Merchan, J. R. & Lima, C. M. R., Feb 1 2018, In : Journal of Gastrointestinal Oncology. 9, 1, p. 135-139 5 p.Research output: Contribution to journal › Article
gemcitabine
Adenocarcinoma
Pancreatic Neoplasms
Disease-Free Survival
Survival
3
Citations
(Scopus)
Molecular effects of stromal-selective targeting by uPAR-retargeted oncolytic virus in breast cancer
Jing, Y., Chavez, V., Ban, Y., Acquavella, N., El-Ashry, D., Pronin, A., Chen, X. & Merchan, J. R., Oct 1 2017, In : Molecular Cancer Research. 15, 10, p. 1410-1420 11 p.Research output: Contribution to journal › Article
Oncolytic Viruses
Measles virus
Breast Neoplasms
Neoplasms
Viruses
30
Citations
(Scopus)
Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma
Narayanan, G., Hosein, P., Beulaygue, I. C., Froud, T., Scheffer, H. J., Venkat, S., Echenique, A., Hevert, E. C., Livingstone, A., Rocha-Lima, C. M., Merchan, J. R., Levi, J., Yrizarry, J. & Lencioni, R., Mar 1 2017, In : Journal of Vascular and Interventional Radiology. 28, 3, p. 342-348 7 p.Research output: Contribution to journal › Article
Electroporation
Adenocarcinoma
Survival
Safety
Therapeutics